[Cellular adhesion signal transduction network of tumor necrosis factor-alpha induced hepatocellular carcinoma cells]. 2014

Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

OBJECTIVE To systemically explore the cellular adhesion signal transduction network of tumor necrosis factor-alpha (TNF-α)-induced hepatocellular carcinoma cells with bioinformatics tools. METHODS Published microarray dataset of TNF-α-induced HepG2, human transcription factor database HTRI and human protein-protein interaction database HPRD were used to construct and analyze the signal transduction network. RESULTS In the signal transduction network, MYC and SP1 were the key nodes of signaling transduction. Several genes from the network were closely related with cellular adhesion.Epidermal growth factor receptor (EGFR) is a possible key gene of effectively regulating cellular adhesion during the induction of TNF-α. CONCLUSIONS EGFR is a possible key gene for TNF-α-induced metastasis of hepatocellular carcinoma.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
January 1995, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,
Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
April 1999, Journal of cellular physiology,
Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
December 2002, Journal of cardiac failure,
Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
June 2012, Cellular signalling,
Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
October 1996, Annals of the New York Academy of Sciences,
Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
June 2006, The Journal of rheumatology,
Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
November 1996, The Journal of biological chemistry,
Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
December 2002, American journal of physiology. Heart and circulatory physiology,
Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
May 2007, Cancer letters,
Yongchang Zheng, and Shunda Du, and Haifeng Xu, and Yiyao Xu, and Haitao Zhao, and Tianyi Chi, and Xin Lu, and Xinting Sang, and Yilei Mao
July 1998, The Journal of biological chemistry,
Copied contents to your clipboard!